Search Results

There are 15831 results for: content related to: Effect of peroxisome proliferator-activated receptors-γ and co-activator-1α genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people

  1. The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats

    Liver International

    Volume 27, Issue 5, June 2007, Pages: 708–715, Xiang-Qun Deng, Lu-Lu Chen and Ning-Xu Li

    Article first published online : 8 MAY 2007, DOI: 10.1111/j.1478-3231.2007.01497.x

  2. Progression of fibrosis in untreated patients with hepatitis C virus infection

    Liver

    Volume 22, Issue 2, April 2002, Pages: 136–144, L. Martin Lagging, Johan Westin, Elisabeth Svensson, Nibia Aires, Amar P. Dhillon, Magnus Lindh, Rune Wejstål and Gunnar Norkrans

    Article first published online : 23 JAN 2009, DOI: 10.1034/j.1600-0676.2002.01623.x

  3. Macaca radiata (bonnet monkey): a spontaneous model of nonalcoholic fatty liver disease

    Liver International

    Volume 28, Issue 6, July 2008, Pages: 856–864, Perumal Nagarajan, Ramasamy Venkatesan, Mahesh Kumar, Abul Usmani and Subeer S. Majumdar

    Article first published online : 13 MAR 2008, DOI: 10.1111/j.1478-3231.2008.01706.x

  4. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease

    Liver International

    Volume 25, Issue 2, April 2005, Pages: 294–304, Michel Henry Mendler, Gary Kanel and Sugantha Govindarajan

    Article first published online : 17 MAR 2005, DOI: 10.1111/j.1478-3231.2005.01052.x

  5. You have free access to this content
    Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response

    Liver International

    Volume 29, Issue s2, March 2009, Pages: 3–12, Zobair M. Younossi and Arthur J. McCullough

    Article first published online : 28 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01949.x

  6. Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease

    Liver International

    Volume 25, Issue 5, October 2005, Pages: 946–953, Gabriel Perlemuter, Anne Davit-Spraul, Claudine Cosson, Marc Conti, Amélie Bigorgne, Valérie Paradis, Marie-Pierre Corre, Lydie Prat, Viceth Kuoch, Arnaud Basdevant, Gilles Pelletier, Jean-Michel Oppert and Catherine Buffet

    Article first published online : 13 SEP 2005, DOI: 10.1111/j.1478-3231.2005.01126.x

  7. You have free access to this content
    Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data

    Liver International

    Volume 29, Issue s2, March 2009, Pages: 26–37, Francesco Negro and Arun J. Sanyal

    Article first published online : 28 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01950.x

  8. Increased hepatic expression is a major determinant of serum alanine aminotransferase elevation in mice with nonalcoholic steatohepatitis

    Liver International

    Volume 29, Issue 3, March 2009, Pages: 337–343, Rui Liu, Xiaomin Pan and Peter F. Whitington

    Article first published online : 15 AUG 2008, DOI: 10.1111/j.1478-3231.2008.01862.x

  9. You have free access to this content
    The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis

    Liver International

    Volume 30, Issue 6, July 2010, Pages: 795–808, Detlef Schuppan, Mark D. Gorrell, Thomas Klein, Michael Mark and Nezam H. Afdhal

    Article first published online : 31 MAY 2010, DOI: 10.1111/j.1478-3231.2010.02264.x

  10. Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD

    Liver International

    Volume 26, Issue 1, February 2006, Pages: 23–31, Tomoki Nakajima, Michihisa Moriguchi, Tatsuo Katagishi, Satoru Sekoguchi, Taichirou Nishikawa, Hidetaka Takashima, Hiroyuki Kimura, Masahito Minami, Yoshito Itoh, Keizo Kagawa, Yoichi Tani and Takeshi Okanoue

    Article first published online : 31 OCT 2005, DOI: 10.1111/j.1478-3231.2005.01178.x

  11. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease

    Liver International

    Volume 27, Issue 2, March 2007, Pages: 215–219, N. Mendez-Sanchez, D. Zamora-Valdes, R. Pichardo-Bahena, B. Barredo-Prieto, G. Ponciano-Rodriguez, L. Bermejo-Martínez, N. C. Chavez-Tapia, H. A. Baptista-González and M. Uribe

    Article first published online : 14 DEC 2006, DOI: 10.1111/j.1478-3231.2006.01401.x

  12. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

    Liver International

    Volume 25, Issue 4, August 2005, Pages: 779–786, Ayako Suzuki, Paul Angulo, James Lymp, Dave Li, Shinji Satomura and Keith Lindor

    Article first published online : 22 MAR 2005, DOI: 10.1111/j.1478-3231.2005.01064.x

  13. Fenofibrate, a peroxisome proliferator-activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver

    Liver International

    Volume 26, Issue 5, June 2006, Pages: 613–620, Yuichi Harano, Kohichiroh Yasui, Tetsuya Toyama, Tomoki Nakajima, Hironori Mitsuyoshi, Masahito Mimani, Tsutomu Hirasawa, Yoshito Itoh and Takeshi Okanoue

    Article first published online : 28 APR 2006, DOI: 10.1111/j.1478-3231.2006.01265.x

  14. Apocynin alleviated hepatic oxidative burden and reduced liver injury in hypercholesterolaemia

    Liver International

    Volume 27, Issue 4, May 2007, Pages: 529–537, Long-Sheng Lu, Chau-Chung Wu, Li-Man Hung, Meng-Tsan Chiang, Ching-Ting Lin, Chii-Wann Lin and Ming-Jai Su

    Article first published online : 9 MAR 2007, DOI: 10.1111/j.1478-3231.2007.01451.x

  15. You have free access to this content
    Current concepts in the pathogenesis of nonalcoholic fatty liver disease

    Liver International

    Volume 27, Issue 4, May 2007, Pages: 423–433, Nahum Méndez-Sánchez, Marco Arrese, Daniel Zamora-Valdés and Misael Uribe

    Article first published online : 30 MAR 2007, DOI: 10.1111/j.1478-3231.2007.01483.x

  16. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease

    Liver International

    Volume 26, Issue 7, September 2006, Pages: 864–871, Helen Lydatakis, Ieronymos Philippos Hager, Eyaggelia Kostadelou, Stavros Mpousmpoulas, Stavros Pappas and Ioannis Diamantis

    Article first published online : 3 AUG 2006, DOI: 10.1111/j.1478-3231.2006.01312.x

  17. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis

    Liver International

    Volume 28, Issue 7, August 2008, Pages: 1026–1033, Ashkan Farhadi, Sushama Gundlapalli, Maliha Shaikh, Constantine Frantzides, Laura Harrell, Mary M. Kwasny and Ali Keshavarzian

    Article first published online : 7 APR 2008, DOI: 10.1111/j.1478-3231.2008.01723.x

  18. A novel therapeutic drug (copper nicotinic acid complex) for non-alcoholic fatty liver

    Liver International

    Volume 27, Issue 4, May 2007, Pages: 454–464, Ragaa H. M. Salama, Ahmed Y. A. Nassar, Allam A. M. Nafady and Hesham H. T. Mohamed

    Article first published online : 9 MAR 2007, DOI: 10.1111/j.1478-3231.2007.01460.x

    Corrected by:

    ERRATUM

    Vol. 27, Issue 8, 1156, Article first published online: 6 SEP 2007

  19. Diabetic hepatosclerosis: a 10-year autopsy series

    Liver International

    Volume 29, Issue 7, August 2009, Pages: 1044–1050, Guilan Chen and Elizabeth M. Brunt

    Article first published online : 8 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01956.x

  20. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus

    Liver International

    Volume 29, Issue 1, January 2009, Pages: 113–119, Nathalie C. Leite, Gil F. Salles, Antonio L. E. Araujo, Cristiane A. Villela-Nogueira and Claudia R. L. Cardoso

    Article first published online : 1 APR 2008, DOI: 10.1111/j.1478-3231.2008.01718.x